Latest filing published 21 Feb 2013 for Natus Medical INC, €106k.
No signal scores available.
John T. Buhler discloses dealings in 2 companies, chiefly Natus Medical Inc and Senorx Inc. In total, 6 filings cover trades dated from 26 February 2010 to 19 February 2013.
No open-market purchase appears, only 1 sale worth €106k. Outside the open market, there are 3 share grants and 1 option exercise. In 2013 alone, the filings show no purchases and 1 sale.
The latest filing, published on 21 February 2013, reports an open-market sale of €106k in Natus Medical Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations